Malignant Rhabdoid Tumor
10 clinical trials · Condition
◉ Watch Malignant Rhabdoid Tumor
| Record | Firm | Date |
|---|---|---|
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors (NCT04377932) | Baylor College of Medicine | 2021-08-08 |
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors (NCT05103631) | Baylor College of Medicine | 2021-06-17 |
| Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers (NCT04416568) | Dana-Farber Cancer Institute | 2020-08-14 |
| A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT (NCT04897880) | Australian & New Zealand Children's Haematology/Oncology Group | 2019-01-09 |
| Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors (NCT02114229) | St. Jude Children's Research Hospital | 2014-05-14 |
| Tazemetostat Expanded Access Program for Adults With Solid Tumors (NCT03874455) | Epizyme, Inc. |
Track Malignant Rhabdoid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.